Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma

被引:55
作者
Subramanian, VS
Goyal, J
Miwa, M
Sugatami, J
Akiyama, M
Liu, M
Subbaiah, PV
机构
[1] Rush Med Coll, Dept Med, Chicago, IL 60612 USA
[2] Univ Shizuoka, Dept Pharmaco Biochem, Shizuoka, Japan
[3] Rush Med Coll, Dept Biochem, Chicago, IL 60612 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1999年 / 1439卷 / 01期
关键词
lecithin-cholesterol acyltransferase; phospholipase A activity; transacylation; paraoxonase; adhesion molecule;
D O I
10.1016/S1388-1981(99)00072-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine the relative importance of platelet-activating factor-acetylhydrolase (PAF-AH) and lecithin-cholesterol acyltransferase (LCAT) in the hydrolysis of oxidized phosphatidylcholines (OXPCs) to lyso-phosphatidylcholine (lyso-PC), we studied the formation and metabolism of OXPCs in the plasma of normal and PAF-AH-deficient subjects. Whereas the loss of PC following oxidation was similar in the deficient and normal plasmas, the formation of lyse-PC was significantly lower, and the accumulation of OXPC was higher in the deficient plasma. Isolated LDL from the PAF-AH-deficient subjects was more susceptible to oxidation, and stimulated adhesion molecule synthesis in endothelial cells, more than the normal LDL. Oxidation of 16:0-[1-C-14]-18:2 PC, equilibrated with plasma PC, resulted in the accumulation of labeled short- and long-chain OXPCs, in addition to the labeled aqueous products. The formation of the aqueous products decreased by 80%, and the accumulation of short-chain OXPC increased by 110% in the deficient plasma, compared to the normal plasma showing that PAF-AH is predominantly involved in the hydrolysis of the truncated OXPCs. Labeled sn-2-acyl group from the long-chain OXPC was not only hydrolyzed to free fatty acid, but was preferentially transferred to diacylglycerol, in both the normal and deficient plasmas. In contrast, the acyl group from unoxidized PC was transferred only to cholesterol, showing that the specificity of LCAT is altered by OXPC. It is concluded that, while PAF-AH carries out the hydrolysis of mainly truncated OXPCs, LCAT hydrolyzes and transesterifies the long-chain OXPCs. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 109
页数:15
相关论文
共 43 条
  • [1] OXYGEN RADICALS INHIBIT HUMAN PLASMA ACETYLHYDROLASE, THE ENZYME THAT CATABOLIZES PLATELET-ACTIVATING-FACTOR
    AMBROSIO, G
    ORIENTE, A
    NAPOLI, C
    PALUMBO, G
    CHIARIELLO, P
    MARONE, G
    CONDORELLI, M
    CHIARIELLO, M
    TRIGGIANI, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2408 - 2416
  • [2] ARON L, 1978, J BIOL CHEM, V253, P7220
  • [3] Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R
    Aviram, M
    Billecke, S
    Sorenson, R
    Bisgaier, C
    Newton, R
    Rosenblat, M
    Erogul, J
    Hsu, C
    Dunlop, C
    La Du, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) : 1617 - 1624
  • [4] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [5] Bielicki JK, 1996, J LIPID RES, V37, P1012
  • [6] BIELICKI JK, 1995, J LIPID RES, V36, P322
  • [7] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [8] CZARNECKA H, 1993, J BIOL CHEM, V268, P19334
  • [9] PAF-ACETHER-DEGRADING ACETYLHYDROLASE IN PLASMA LDL IS INACTIVATED BY COPPER-MEDIATED AND CELL-MEDIATED OXIDATION
    DENTAN, C
    LESNIK, P
    CHAPMAN, MJ
    NINIO, E
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (03): : 353 - 360
  • [10] Mechanisms of disease - Antioxidants and atherosclerotic heart disease
    Diaz, MN
    Frei, B
    Vita, JA
    Keaney, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) : 408 - 416